Previous 10 | Next 10 |
2024-01-10 08:30:36 ET NetworkNewsWire Editorial Coverage New York, NY – January 10, 2024 – On Sept. 20, 2019, history was made when the U.S. Food and Drug Administration approved Rybelsus as the first oral glucagon-like peptide-1 (GLP-1) agonist for type 2 dia...
2024-01-05 13:30:11 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips In the Big Pharma space, weight-loss-related drugs are gaining a lot of attention. Accordingly, for investors attempting to gauge the impact of these drugs on certain businesses, there’s...
2024-01-05 11:00:12 ET More on Consumer Discretionary: XLY: Consumer Discretionary Dashboard For December Wall Street Breakfast Catalyst Watch: Is Consumer Sentiment Just Another Data Point In The Mix? XLY: Consumer Discretionary Dashboard For October Consume...
2024-01-05 08:42:38 ET WW International (NASDAQ: WW) was going through quite a slimdown this week, at least as far as its stock was concerned. Investors traded out of the WeightWatchers parent company following a downbeat note from a researcher, and the introduction of a competi...
2024-01-04 14:24:43 ET Shares of WW International (NASDAQ: WW) , formerly Weight Watchers International, tumbled 11.4% through 1:10 p.m. ET on Thursday at the same time as Eli Lilly (NYSE: LLY) stock resumed its relentless march back toward its 52 week high. These two ev...
2024-01-04 12:43:30 ET More on Him & Hers, LifeMD, etc. Hims & Hers Health: Faultless, Ready To Go Higher Hims & Hers: New Weight Loss Category Is A Prescription For Explosive Growth And Upward Revisions Hims & Hers Health: Promising Catalysts To Driv...
2024-01-04 11:26:55 ET More on Consumer Discretionary Select Sector SPDR ETF XLY: Consumer Discretionary Dashboard For December Wall Street Breakfast Catalyst Watch: Is Consumer Sentiment Just Another Data Point In The Mix? XLY: Consumer Discretionary Dashboard For O...
2024-01-03 15:09:50 ET More on S&P 500 Index: What The Fed Will Do After The December Jobs Report Nothing More Than Resolving An Overbought Condition Update: Fund-Flows In The Economy And Their Effect On The Stock Market The market should watch out for cr...
2024-01-02 12:26:25 ET More on Parker-Hannifin: Parker Hannifin: This Dividend King Is Still A Buy Near All-Time Highs Parker-Hannifin: Good Growth Prospects And Potential For Further Re-Rating Parker-Hannifin: Re-Rating Nears Completion GE, Honeywell are amo...
2023-12-29 21:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 07:00:08 ET Nathan Feather from Morgan Stanley issued a price target of $1.25 for WW on 2024-07-26 05:48:00. The adjusted price target was set to $1.25. At the time of the announcement, WW was trading at $1.32. The overall price target consensus is at $6.00 wi...
NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the second quarter 2024 before market open on Thursday, August 1, 2024. WeightWatchers will host ...